Yüklüyor......

Antitumor activity of sorafenib and imatinib in a patient with thymic carcinoma harboring c-KIT exon 13 missense mutation K642E

We report the case of a man with an advanced nonkeratinizing squamous cell thymic carcinoma harboring c-KIT exon 13 missense mutation K642E. This aberration is rare and has never been described previously in patients with thymic cancers. It has been found in a small number of cases of gastrointestin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Catania, Chiara, Conforti, Fabio, Spitaleri, Gianluca, Barberis, Massimo, Preda, Lorenzo, Noberasco, Cristina, Lazzari, Chiara, Toffalorio, Francesca, de Marinis, Filippo, Manzotti, Michela, De Pas, Tommaso Martino
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4020909/
https://ncbi.nlm.nih.gov/pubmed/24855380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S58902
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!